Interim Associate Director, Translational Research - Amy Heimberger, MD
The associate director for Translational Research is appointed by and reports to the director of the Lurie Cancer Center. The position is responsible for the development and coordination of translational research efforts within the Lurie Cancer Center.
A renowned neurosurgical oncologist and expert in immunotherapies, Amy Heimberger, MD, is the Jean Malnati Miller Professor of Brain Tumor Research and vice chair for research in in the Department of Neurological Surgery. Her research focuses on immune therapeutic strategies for patients with central nervous system malignancies and tumor-mediated mechanisms of immune suppression.
Heimberger has been involved in a wide variety of bench-to-bedside immune therapeutics, including those developed in her laboratory and arising from her own patents. She has expertise in the investigational new drug application process, and has been the principal investigator of multiple clinical trials.
In 2021, she was named by President Biden to the National Cancer Advisory Board.